Atlas Trials

Chronic Lymphocytic Leukaemia

20 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Chronic Lymphocytic Leukaemia

RecordFirmDate
First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies (NCT04763083)NovalGen Ltd.2021-05-14
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003) (NCT04728893)Merck Sharp & Dohme LLC2021-04-05
Clinical Outcomes and Routine Management of Adults With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and Ireland (NCT03582098)Gilead Sciences2018-09-12
BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia (NCT02933320)Cancer Research UK2016-10-27
Tissue Collection for Biomarkers Determining Resistance to Ibrutinib (NCT02267590)Royal Marsden NHS Foundation Trust2014-10-01
A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies (NCT01805375)Cancer Research UK2013-04-01
Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers (NCT01597219)University College, London2013-03-01
Study to Evaluate the Safety and Tolerability of Tirabrutinib (ONO/GS-4059) Given as Monotherapy in Participants With Relapsed/Refractory NHL and CLL (NCT01659255)Gilead Sciences2012-08-17
A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive Treatment (NCT01678430)University of Liverpool2011-12-01
Efficacy and Safety Study of Bendamustine With or Without Rituximab in Chronic Lymphoproliferative Disorders (NCT01832597)Gruppo Italiano Studio Linfomi2010-11-01
RESPeCT: Revlimid Early Stage Poor Prognosis Chronic Lymphocytic Leukaemia (CLL) Trial (NCT01127542)The Christie NHS Foundation Trust2010-05-01
R-CHOP and Alemtuzumab in Patients With Chronic Lymphocytic Leukemia (NCT00504491)CABYC2007-07-01
A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma (NCT00457782)Kyowa Kirin Co., Ltd.2007-04-01
Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL) (NCT00751296)University Health Network, Toronto2006-08-01
A Single-arm Phase II Study of Alemtuzumab in Combination With High-dose Methylprednisolone in CLL Patients With p53 Deletion (NCT00292760)Royal Marsden NHS Foundation Trust

Track Chronic Lymphocytic Leukaemia automatically

Every clearance here is in the API, with alerts when new ones post.